速效门冬胰岛素与标准门冬胰岛素在1型糖尿病全天候全闭环胰岛素治疗中的比较:双盲随机交叉试验
本研究在20例1型糖尿病年轻成人中,采用双盲随机交叉设计,比较使用速效门冬胰岛素(Faster-CL)与标准门冬胰岛素(Standard-CL)进行全天候全闭环胰岛素治疗的安全性和有效性。主要终点为27小时内血糖在70-180 mg/dL的时间比例(TIR),结果显示两组TIR相似(53.3% vs 57.9%,P=0.170),低血糖时间均为0.0%,无严重不良事件。结论认为两种胰岛素均安全有效,但闭环算法对标准门冬胰岛素调整更佳。
要点
- 速效与标准门冬胰岛素全闭环治疗的TIR相似,低血糖风险极低。
- 速效胰岛素组餐后1小时血糖增幅更大,算法对标准胰岛素适应性更好。
- 两种胰岛素在全闭环治疗中均安全,无严重不良事件。
核心结论
- 使用速效或标准门冬胰岛素的全闭环胰岛素输送均安全有效,可在非餐后时段达到接近正常的血糖浓度。
- 闭环算法对标准门冬胰岛素的调整更佳。
研究设计与样本
- 双盲、随机、交叉试验,纳入20例使用胰岛素泵治疗的1型糖尿病年轻成人(11例女性,年龄21.3±2.3岁,HbA1c 7.5±0.5% [58.5±5.5 mmol/mol])。
- 受试者接受两个27小时住院阶段,包含非预告的下午中高强度运动和未告知/未覆盖的餐食,随机顺序比较Faster-CL和Standard-CL。
- 两阶段均使用模糊逻辑控制算法DreaMed GlucoSitter,传感器葡萄糖数据按意向性治疗原则分析。
主要发现
- 主要终点27小时内TIR(70-180 mg/dL)比例两组相似:Faster-CL为53.3%(过夜83%),Standard-CL为57.9%(过夜88%),P=0.170。
- 低血糖(<70 mg/dL)时间比例两组均为0.0%。
- 餐后1小时基线调整后的间质葡萄糖增幅Faster-CL大于Standard-CL(P=0.017)。
- 运动开始、结束及运动后2小时,实测血浆胰岛素与估计胰岛素-on-board水平的差距在Standard-CL组更小(P=0.029、P=0.003、P=0.004)。
- 无严重不良事件发生。
临床怎么用
- 对于使用全闭环系统的1型糖尿病患者,标准门冬胰岛素可能因算法适配性更好而更有利于血糖控制。
- 速效门冬胰岛素在全闭环治疗中安全有效,但需注意餐后血糖增幅可能更大。
局限性
- 样本量较小(20例),研究周期短(27小时住院阶段)。
- 研究对象为年轻成人,结果可能不适用于其他年龄组。
- 算法为特定模糊逻辑控制算法(DreaMed GlucoSitter),结果可能不适用于其他闭环系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated the safety and efficacy of day-and-night fully closed-loop insulin therapy using faster (Faster-CL) compared with standard insulin aspart (Standard-CL) in young adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: In a double-blind, randomized, crossover trial, 20 participants with type 1 diabetes on insulin pump therapy (11 females, aged 21.3 ± 2.3 years, HbA1c 7.5 ± 0.5% [58.5 ± 5.5 mmol/mol]) underwent two 27-h inpatient periods with unannounced afternoon moderate-vigorous exercise and unannounced/uncovered meals. We compared Faster-CL and Standard-CL in random order. During both interventions, the fuzzy-logic control algorithm DreaMed GlucoSitter was used. Glucose sensor data were analyzed by intention-to-treat principle with the difference (between Faster-CL and Standard-CL) in proportion of time in range 70-180 mg/dL (TIR) over 27 h as the primary end point. RESULTS: The proportion of TIR was similar for both arms: 53.3% (83% overnight) in Faster-CL and 57.9% (88% overnight) in Standard-CL (P = 0.170). The proportion of time in hypoglycemia <70 mg/dL was 0.0% for both groups. Baseline-adjusted interstitial prandial glucose increments 1 h after meals were greater in Faster-CL compared with Standard-CL (P = 0.017). The gaps between measured plasma insulin and estimated insulin-on-board levels at the beginning, at the end, and 2 h after the exercise were smaller in the Standard-CL group (P = 0.029, P = 0.003, and P = 0.004, respectively). No severe adverse events occurred. CONCLUSIONS: Fully closed-loop insulin delivery using either faster or standard insulin aspart was safe and efficient in achieving near-normal glucose concentrations outside postprandial periods. The closed-loop algorithm was better adjusted to the standard insulin aspart.
引用
- Dovc K, Piona C, Yeşiltepe Mutlu G, et al. Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial. Diabetes Care. 2019. PMID: 31575640. doi:10.2337/dc19-0895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。